The synthesis of 5H-imidazo[4,5-c]pyridines analogues (1a − 1h) and 4H-imidazo[4,5-b]pyridines (3a − 3c) was achieved by reacting 3,4-diaminopyridine or 2,3-diaminopyridine with Na₂S₂O₅ adduct of corresponding benzaldehydes (a1 - a8). Alkylation of compounds (1a − 1h) and (3a − 3c) using 4-chlorobenzyl and /or butyl bromide under basic conditions (K₂CO₃, DMF) predominantly resulted in the formation of N⁵ regioisomers (2a − 2l) and N^4,3 regioisomers (4a − 4c_1,2), respectively. The N^5,4,3-regioisomeric structures were confirmed using 2D-NOESY (Nuclear Overhauser Effect Spectroscopy) and HMBC (Heteronuclear Multiple Bond Correlation) spectra. The antibacterial and antifungal activities of the synthesized compounds (2a − 2g, 4a − 5d) were evaluated in vitro against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Methicillin resistant S. aureus, Enterococcus faecalis and Candida albicans, Candida parapsilosis. Among the synthesized compounds, promising activities were observed with compounds 2g, 2h, 4a and 4b with lowest MIC values (4–8 µg/mL). The compounds 2i, 2j, 2k, 2l showed moderate activity. Additionally, a computational approach (ADMETlab 2.0) was used to evaluate the drug likeness properties of the compounds.